Antibacterial agents that inhibit two-component signal transduction systems. - Wikidata - awgldk - TriplyDB

Antibacterial agents that inhibit two-component signal transduction systems.

Antibacterial agents that inhibit two-component signal transduction systems.

http://www.wikidata.org/entity/Q36069845

about

MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30(T), against methicillin-resistant Staphylococcus aureus NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ The phosphate regulon and bacterial virulence: a regulatory network connecting phosphate homeostasis and pathogenesis Antifungal properties and target evaluation of three putative bacterial histidine kinase inhibitors A two-component signal transduction system with a PAS domain-containing sensor is required for virulence of Mycobacterium tuberculosis in mice Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus Inhibitors of bacterial two-component signalling systems.A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases A two-component signal transduction system essential for growth of Bacillus subtilis: implications for anti-infective therapy.Genetic analysis of the functions and interactions of components of the LevQRST signal transduction complex of Streptococcus mutans.Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8 Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus.Histidine phosphotransfer proteins in fungal two-component signal transduction pathways.Fungal histidine kinases.Combination approaches to combat multidrug-resistant bacteria.The QseC sensor kinase: a bacterial adrenergic receptor Virulence as a target for antimicrobial chemotherapy.Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.Adaptation to environmental stimuli within the host: two-component signal transduction systems of Mycobacterium tuberculosis.The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii.Can virulence factors be viable antibacterial targets?In vivo characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in Escherichia coli: a nonpathogenic model for studying the VRE signal transduction pathways Probing the roles of the two different dimers mediated by the receiver domain of the response regulator PhoB.Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections.Attractive reactivity of a natural product, zerumbone.C. pseudotuberculosis Phop confers virulence and may be targeted by natural compounds.Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system.Dissecting the VanRS signal transduction pathway with specific inhibitors.Avirulence of Candida albicans CaHK1 mutants in a murine model of hematogenously disseminated candidiasis Crystal structure of the response regulator 02 receiver domain, the essential YycF two-component system of Streptococcus pneumoniae in both complexed and native states.The mechanism of action of inhibitors of bacterial two-component signal transduction systems.Crystallization and preliminary X-ray analysis of the receiver domain of a putative response regulator, BPSL0128, from Burkholderia pseudomallei.Mechanistic insight into inhibition of two-component system signaling.Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent.Teaching old drugs new tricks: Addressing resistance in Francisella.A genomic analysis of two-component signal transduction in Streptococcus pneumoniae.Bacterial 2-component signal transduction systems: a fluorescence polarization screen for response regulator-protein binding.The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus.Purification, reconstitution, and characterization of the CpxRAP envelope stress system of Escherichia coli.

P2860

Q24554342-6CC4B845-B56D-4966-84D9-7D7816CCC650 Q27766026-0B9ABDE4-4C1E-4071-AD72-DC8F838B96F5 Q28267290-4111DE24-DE47-426C-BECA-890A6CCF0695 Q28343415-EF686070-5C0B-4254-941E-96EB23B4C295 Q28487520-5329F5C9-E7B1-46CC-BB16-C88108345104 Q28539903-B87A832E-98F4-44F7-B0AA-406D190A017E Q33181385-85F94714-9620-42EF-96C1-E6E7AED14DEB Q33738068-FD493C63-0D3A-431A-8A32-1C8ECEFD8077 Q33743781-01CA4E06-6E67-4F66-AE92-313E83665E99 Q33833833-0DCADA05-0A81-4113-87F7-CED115012CF7 Q33966856-5040539F-0DAE-46ED-BB7E-80C91A22FA11 Q33977169-B55F3CAA-A2AA-4B83-B05F-4EC5E9AF0DC3 Q33995526-BBAA4D29-9035-4649-BF99-345021DEAF7C Q34351272-F0F375F8-197B-4421-98A8-1801E6434358 Q34467977-8316533D-8770-43A5-A5BC-CE3CBD11921F Q34554879-8A620018-63D6-497E-BACF-4643DC88A12C Q34652404-AD5C1AD6-EE0C-4FA2-A8C5-617C11288138 Q34768578-2CA9AA9D-0CBF-4586-81C0-74BED45F174F Q34823364-6095C560-17B1-4CC9-8D67-6ED9E8F15064 Q35598334-47AF2F99-5040-4450-80E5-017476EF50A3 Q35841626-72A79104-E8DE-4C71-851D-EA143199EA9E Q35917322-8385E16E-211C-4F89-A893-FD5F4FA21B8A Q36327115-85571E6B-05EF-447A-907A-A19EBC56C040 Q37276243-4893878F-C710-4C63-9716-E71E5F33F0F3 Q37590383-C5B3F3BF-49A5-44DE-A83F-F9DED906CDB5 Q37838634-318202E5-17B2-43ED-BBD6-8AE587299B3D Q38957444-CD8E1446-CD81-462C-ADE3-87D6AE18B1F3 Q39473957-7054BAB7-44AB-41FF-ACF4-F67B58BF2CEE Q39493871-A38BAE44-2875-497C-9486-73F3E5DCDC40 Q39511574-0D444919-D1A5-46F5-B352-A8AD5AF54231 Q40763474-4F580392-7E34-4BBF-9232-33888DD3FDC1 Q41760386-2B4D6659-64CE-46B1-B079-D3B63656B50E Q41999975-23B9DC9C-1DBB-4095-B213-9D17A993C3ED Q42748326-C667BD1D-AD05-42B4-BE1E-9A1D94BFA36F Q43207922-57DAE5E4-AC89-48ED-AFF4-68642C334201 Q43226628-1D9F248E-53DE-4C33-9CF8-5BDA698F7F63 Q44768445-D56DA937-05E8-440D-9FC1-4AC93236CAB6 Q46421325-AA708226-05F3-4BC1-B8A9-202D48DEE139 Q49970485-308221A1-B673-4D30-A82C-01C698C71575 Q52927769-E7687631-568D-4C7D-9526-6C244BB7480B

P2860

Antibacterial agents that inhibit two-component signal transduction systems.

http://www.wikidata.org/entity/Q36069845

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Antibacterial agents that inhibit two-component signal transduction systems.

@ast

Antibacterial agents that inhibit two-component signal transduction systems.

@en

type

label

Antibacterial agents that inhibit two-component signal transduction systems.

@ast

Antibacterial agents that inhibit two-component signal transduction systems.

@en

prefLabel

Antibacterial agents that inhibit two-component signal transduction systems.

@ast

Antibacterial agents that inhibit two-component signal transduction systems.

@en

P1433

Q36069845-B5E17067-BAA4-47DA-83D2-F2DCA900BCBB

P1476

Q36069845-4C2E3334-3CF5-4DFC-B73C-8C03AB36CCAF

P2093

Q36069845-001B5127-C70D-4CD2-B1A9-FE0AB44B6A2B

Q36069845-0F9BAABD-0123-4EC9-9798-7F8191A0A1E5

Q36069845-11C093A1-5182-4DF4-A820-20C0691ABDEE

Q36069845-376F4D94-B101-4F7A-AB12-B185A8A60D82

Q36069845-4EF8F327-666A-4640-B887-B885CF81129F

Q36069845-5868AF82-EED6-406C-B7BE-E5D28347EA1C

Q36069845-6A727BD1-D014-4CDE-B2DE-253D47CF16A5

Q36069845-6ABB7764-73BE-4602-86EB-468529C86C5F

Q36069845-70F3F139-C81C-4837-89D1-D4D458C93A69

Q36069845-72810EDF-EF14-4216-B11C-A3EF9A0271FD

P2860

Q36069845-0F22190F-8651-46D0-A832-20049FC610A7

Q36069845-16416F7E-AE31-49DF-A599-1619D70C80A0

Q36069845-1E72EED8-239A-4E13-9B0E-FDE1C939957B

Q36069845-25C2B975-F5D7-4A47-A527-B6473FFB1A9C

Q36069845-29AA2E38-F8A1-4187-B003-16F2E6319D82

Q36069845-2BC1B5EE-1CEA-416F-B444-0DC71191C7FF

Q36069845-364A5C5B-9D06-4658-980D-F34D1782BD64

Q36069845-3820FF0D-4AC1-4D50-91B3-AEB461285646

Q36069845-4201545E-7F35-4F37-BED5-F8C6BDB31797

Q36069845-43D20E55-B26D-4DBD-A601-127473B2C83C

P304

Q36069845-FE6B8FDE-C907-4FB2-A9FC-C8566DC768E8

P31

Q36069845-40A494A0-3377-459A-93E3-250CA0494347

P356

Q36069845-BEEE8518-FD23-4409-A86A-7E3B17370785

P407

Q36069845-75821E2A-67AF-4953-9042-085C88551710

P433

Q36069845-8E674FC6-4D42-408D-8F42-FB477B4FB07D

P478

Q36069845-CABF48B8-8B01-4840-94DD-7BF410F670E9

P577

Q36069845-CEC9D040-6FD0-440B-8004-A225BE2210B9

P5875

Q36069845-D6046BDC-9F70-464E-BC1D-CAF2798AE72A

P698

Q36069845-F1F75834-696B-4D84-B1C3-8F349AD44E9C

P932

Q36069845-12A6E15F-EFA4-4336-8DC3-7BFC8ECCBBA9

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antibacterial agents that inhibit two-component signal transduction systems.

@en

P2093

Barrett JF

http://www.w3.org/2001/XMLSchema#string

Bernstein J

http://www.w3.org/2001/XMLSchema#string

Chen R

http://www.w3.org/2001/XMLSchema#string

Demers JP

http://www.w3.org/2001/XMLSchema#string

Donetz A

http://www.w3.org/2001/XMLSchema#string

Fernandez J

http://www.w3.org/2001/XMLSchema#string

Foleno B

http://www.w3.org/2001/XMLSchema#string

Frechette R

http://www.w3.org/2001/XMLSchema#string

Frosco MB

http://www.w3.org/2001/XMLSchema#string

Goldschmidt RM

http://www.w3.org/2001/XMLSchema#string

P2860

The Minimal Gene Complement of Mycoplasma genitalium

Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

The complete genome sequence of the gram-positive bacterium Bacillus subtilis

Protein phosphorylation and regulation of adaptive responses in bacteria

The complete genome sequence of Escherichia coli K-12

Whole-genome random sequencing and assembly of Haemophilus influenzae Rd

A two-component system that regulates an osmosensing MAP kinase cascade in yeast.

Yeast HOG1 MAP kinase cascade is regulated by a multistep phosphorelay mechanism in the SLN1-YPD1-SSK1 "two-component" osmosensor.

Communication modules in bacterial signaling proteins

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

P304

5317-5322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.9.5317

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13720708

http://www.w3.org/2001/XMLSchema#string

P698

9560273

http://www.w3.org/2001/XMLSchema#string

P932

20258

http://www.w3.org/2001/XMLSchema#string